GB0521509D0 - Organic molecules - Google Patents

Organic molecules

Info

Publication number
GB0521509D0
GB0521509D0 GB0521509A GB0521509A GB0521509D0 GB 0521509 D0 GB0521509 D0 GB 0521509D0 GB 0521509 A GB0521509 A GB 0521509A GB 0521509 A GB0521509 A GB 0521509A GB 0521509 D0 GB0521509 D0 GB 0521509D0
Authority
GB
United Kingdom
Prior art keywords
organic molecules
molecules
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0521509A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GB0521509A priority Critical patent/GB0521509D0/en
Publication of GB0521509D0 publication Critical patent/GB0521509D0/en
Priority to KR1020087009313A priority patent/KR20080049113A/en
Priority to US12/091,020 priority patent/US7910708B2/en
Priority to BRPI0617485A priority patent/BRPI0617485B8/en
Priority to PCT/EP2006/010098 priority patent/WO2007045477A2/en
Priority to EP12172979A priority patent/EP2532677A1/en
Priority to MYPI20081170A priority patent/MY144906A/en
Priority to PL12173018T priority patent/PL2532679T3/en
Priority to UAA200804983A priority patent/UA96426C2/en
Priority to KR1020137002695A priority patent/KR20130020850A/en
Priority to CA2625664A priority patent/CA2625664C/en
Priority to PT121730188T priority patent/PT2532679T/en
Priority to EP06806402A priority patent/EP1957530A2/en
Priority to AU2006303452A priority patent/AU2006303452B2/en
Priority to EP12173018.8A priority patent/EP2532679B1/en
Priority to CN2006800374681A priority patent/CN101287760B/en
Priority to RU2008119689/10A priority patent/RU2421464C2/en
Priority to PE2006001269A priority patent/PE20080036A1/en
Priority to NZ567124A priority patent/NZ567124A/en
Priority to ARP060104563A priority patent/AR058104A1/en
Priority to KR1020107028697A priority patent/KR101461263B1/en
Priority to EP12173002A priority patent/EP2532678A1/en
Priority to JP2008535972A priority patent/JP5006330B2/en
Priority to TW095138861A priority patent/TWI431013B/en
Priority to ZA200802541A priority patent/ZA200802541B/en
Priority to IL190332A priority patent/IL190332A/en
Priority to CR9867A priority patent/CR9867A/en
Priority to MA30847A priority patent/MA29869B1/en
Priority to EC2008008388A priority patent/ECSP088388A/en
Priority to TNP2008000175A priority patent/TNSN08175A1/en
Priority to NO20082309A priority patent/NO20082309L/en
Priority to US12/975,667 priority patent/US8580260B2/en
Priority to JP2012050499A priority patent/JP5684174B2/en
Priority to US14/044,314 priority patent/US8992916B2/en
Priority to US14/629,587 priority patent/US9650438B2/en
Ceased legal-status Critical Current

Links

GB0521509A 2005-10-21 2005-10-21 Organic molecules Ceased GB0521509D0 (en)

Priority Applications (35)

Application Number Priority Date Filing Date Title
GB0521509A GB0521509D0 (en) 2005-10-21 2005-10-21 Organic molecules
PE2006001269A PE20080036A1 (en) 2005-10-21 2006-10-19 HUMAN ANTIBODIES TO INTERLEUKIN-13 (IL13)
RU2008119689/10A RU2421464C2 (en) 2005-10-21 2006-10-19 Human il-13 antibodies and their therapeutic application
NZ567124A NZ567124A (en) 2005-10-21 2006-10-19 Human antibodies against Interleukin-13 and therapeutic uses to treat asthma
BRPI0617485A BRPI0617485B8 (en) 2005-10-21 2006-10-19 isolated anti-human IL-13 antibody, pharmaceutical composition and use of said antibody
US12/091,020 US7910708B2 (en) 2005-10-21 2006-10-19 Anti-IL13 human antibodies
EP12172979A EP2532677A1 (en) 2005-10-21 2006-10-19 Human antibodies against il13 and therapeutic uses
ARP060104563A AR058104A1 (en) 2005-10-21 2006-10-19 ORGANIC COMPOUNDS
PL12173018T PL2532679T3 (en) 2005-10-21 2006-10-19 Human antibodies against il13 and therapeutic uses
UAA200804983A UA96426C2 (en) 2005-10-21 2006-10-19 Isolated human or humanized antibody that specifically binds to il-13
KR1020137002695A KR20130020850A (en) 2005-10-21 2006-10-19 Human antibodies against il-13 and therapeutic uses
CA2625664A CA2625664C (en) 2005-10-21 2006-10-19 Human antibodies against il13 and therapeutic uses
PT121730188T PT2532679T (en) 2005-10-21 2006-10-19 Human antibodies against il13 and therapeutic uses
EP06806402A EP1957530A2 (en) 2005-10-21 2006-10-19 Human antibodies against il13 and therapeutic uses
AU2006303452A AU2006303452B2 (en) 2005-10-21 2006-10-19 Human antibodies against IL13 and therapeutic uses
EP12173018.8A EP2532679B1 (en) 2005-10-21 2006-10-19 Human antibodies against il13 and therapeutic uses
CN2006800374681A CN101287760B (en) 2005-10-21 2006-10-19 Anti-IL13 human antibodies
KR1020087009313A KR20080049113A (en) 2005-10-21 2006-10-19 Human antibodies against il-13 and therapeutic uses
JP2008535972A JP5006330B2 (en) 2005-10-21 2006-10-19 Human antibodies against IL13 and therapeutic uses
PCT/EP2006/010098 WO2007045477A2 (en) 2005-10-21 2006-10-19 Human antibodies against il-13 and therapeutic uses
MYPI20081170A MY144906A (en) 2005-10-21 2006-10-19 Human antibodies against il13 and therapeutic uses
KR1020107028697A KR101461263B1 (en) 2005-10-21 2006-10-19 Human antibodies against IL-13 and therapeutic uses
EP12173002A EP2532678A1 (en) 2005-10-21 2006-10-19 Human antibodies against il13 and therapeutic uses
TW095138861A TWI431013B (en) 2005-10-21 2006-10-20 Organic molecules
ZA200802541A ZA200802541B (en) 2005-10-21 2008-03-19 Human antibodies against IL13 and therapeutic uses
IL190332A IL190332A (en) 2005-10-21 2008-03-20 Isolated human or humanized il 13 antibody comprising an antigen-binding region and pharmaceutical composition comprising it
CR9867A CR9867A (en) 2005-10-21 2008-04-04 HUMAN ANTIBODIES AGAINST IL13 AND THERAPEUTIC USES
MA30847A MA29869B1 (en) 2005-10-21 2008-04-15 ORGANIC MOLECULES
TNP2008000175A TNSN08175A1 (en) 2005-10-21 2008-04-18 Human antibodies against il-13 and therapeutic uses
EC2008008388A ECSP088388A (en) 2005-10-21 2008-04-18 HUMAN ANTIBODIES AGAINST IL13 AND THERAPEUTIC USES
NO20082309A NO20082309L (en) 2005-10-21 2008-05-21 Organic molecules
US12/975,667 US8580260B2 (en) 2005-10-21 2010-12-22 Method of using anti-IL-13 antibodies
JP2012050499A JP5684174B2 (en) 2005-10-21 2012-03-07 Human antibodies against IL13 and therapeutic uses
US14/044,314 US8992916B2 (en) 2005-10-21 2013-10-02 Methods of using anti-IL13 human antibodies
US14/629,587 US9650438B2 (en) 2005-10-21 2015-02-24 Nucleic acid encoding anti-IL13 human antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0521509A GB0521509D0 (en) 2005-10-21 2005-10-21 Organic molecules

Publications (1)

Publication Number Publication Date
GB0521509D0 true GB0521509D0 (en) 2005-11-30

Family

ID=35458484

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0521509A Ceased GB0521509D0 (en) 2005-10-21 2005-10-21 Organic molecules

Country Status (5)

Country Link
CN (1) CN101287760B (en)
GB (1) GB0521509D0 (en)
TN (1) TNSN08175A1 (en)
UA (1) UA96426C2 (en)
ZA (1) ZA200802541B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106749674A (en) * 2016-12-23 2017-05-31 四川大学 A kind of new asthma polypeptide vaccine and preparation method thereof
CN109776677B (en) * 2017-11-15 2023-11-03 尚华科创投资管理（江苏）有限公司 Humanized anti-IL-13 antibody and preparation method and application thereof

Also Published As

Publication number Publication date
UA96426C2 (en) 2011-11-10
TNSN08175A1 (en) 2009-10-30
CN101287760B (en) 2012-10-17
CN101287760A (en) 2008-10-15
ZA200802541B (en) 2009-10-28

Similar Documents

Publication Publication Date Title
GB0510390D0 (en) Organic compounds
EP1888534A4 (en) Organic compounds
GB0507575D0 (en) Organic compounds
GB0500435D0 (en) Organic compounds
GB0500785D0 (en) Organic compounds
GB0508319D0 (en) Organic compounds
GB0505969D0 (en) Organic compounds
GB0502358D0 (en) Organic compounds
GB0507696D0 (en) Organic compounds
GB0505219D0 (en) Organic compounds
GB0507577D0 (en) Organic compounds
GB0503646D0 (en) Organic compounds
GB0504850D0 (en) Organic compounds
GB0507298D0 (en) Organic compounds
GB0504194D0 (en) Organic compounds
GB0504544D0 (en) Organic compounds
GB0510810D0 (en) Organic compounds
GB0508992D0 (en) Organic compounds
GB0500784D0 (en) Organic compounds
GB0501237D0 (en) Organic compounds
GB0504203D0 (en) Organic compounds
GB0500020D0 (en) Organic compounds
GB0500683D0 (en) Organic compounds
GB0507695D0 (en) Organic compounds
GB0505541D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)